Guest editors Jonathan Wingfield and Ian Wilson
“Advances in Mass Spectrometry within Drug Discovery” is the theme of this special issue. A dozen peer-reviewed original research reports from the UK, US, Singapore and Australia demonstrate new ways in which mass spectrometry (MS) has evolved from a specialist technique, used initially almost exclusively for structure determination, to one where the bulk of applications now revolve around routine applications in analyte detection and quantification.
Jonathan Wingfield and Ian D. Wilson
Advances in Mass Spectrometry Within Drug Discovery
J Biomol Screen February 2016 21: 109-110, doi:10.1177/1087057115623454